Table 1.
Patient characteristics by treatment period.
Figure 1.
DSS of patients with de novo mRCC diagnosed from 1992–2004 as compared to 2005–2009.
Figure 2.
DSS of patients with de novo mRCC diagnosed from 1992–2004 as compared to 2005–2009 with clear cell disease.
Figure 3.
DSS of patients with de novo mRCC diagnosed from 1992–2004 as compared to 2005–2009 with non-clear cell (i.e., papillary or chromophobe) disease.
Table 2.
Univariate and multivariate analysis of DSS.